🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Medice Arzneimittel Putter GmbH & Co. K.G — Licensed Medicines

22 medicines held by Medice Arzneimittel Putter GmbH & Co. K.G on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 22 products held by Medice Arzneimittel Putter GmbH & Co. K.G
MedicineActive substanceLicence holderStatus
Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/412/1-2
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/412/15-16
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/412/3-4
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 20 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/412/021-22
Epoetin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 3 000 IU/0.3 mL solution for injection in a pre-filled syringe
EU/1/07/412/5-6
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 30 000 IU/0.75 mL solution for injection in a pre-filled syringe
EU/1/07/412/023-24
Epoetin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 4 000 IU/0.4 mL solution for injection in a pre-filled syringe
EU/1/07/412/7-8
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 40 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/412/025-26
Epoetin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 5 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/412/9-10
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 6 000 IU/0.6 mL solution for injection in a pre-filled syringe
EU/1/07/412/11-12
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Abseamed 8 000 IU/0.8 mL solution for injection in a pre-filled syringe
EU/1/07/412/13-14
Recombinant human erythropoietin alfa Medice Arzneimittel Putter GmbH & Co. K.G
Medikinet 10 mg tablets
PA1555/001/007
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet 20 mg tablets
PA1555/001/008
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet 5 mg tablets
PA1555/001/006
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 10mg modified – release capsules, hard
PA1555/001/002
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 20mg modified – release capsules, hard
PA1555/001/003
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 30mg modified – release capsules, hard
PA1555/001/004
Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 40mg modified – release capsules, hard
PA1555/001/005
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
Medikinet MR 5mg modified – release capsules, hard
PA1555/001/001
Methylphenidate hydrochloride, Methylphenidate hydrochloride Medice Arzneimittel Putter GmbH & Co. K.G Marketed
VAFSEO 150 mg Film-coated tablet
EU/1/23/1725/001-002
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
VAFSEO 300 mg Film-coated tablet
EU/1/23/1725/003-004
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
VAFSEO 450 mg Film-coated tablet
EU/1/23/1725/005-006
Vadadustat Medice Arzneimittel Putter GmbH & Co. K.G
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.